Ulcerative Colitis-Induced Colorectal Carcinoma: A Deleterious Concatenation

Inflammatory bowel disease (IBD) is a chronic inflammatory gastrointestinal ailment that encompasses Crohn's disease (CD) and ulcerative colitis (UC). UC is an idiopathic, chronic inflammatory condition of the colonic mucosa that begins in the rectum and progresses proximally in a continuous wa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Curēus (Palo Alto, CA) CA), 2022-02, Vol.14 (2), p.e22636-e22636
Hauptverfasser: Rivera, Ana P, Flores Monar, Gabriela Vanessa, Islam, Hamza, Puttagunta, Sri Madhurima, Islam, Rabia, Kundu, Sumana, Jha, Surajkumar B, Sange, Ibrahim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e22636
container_issue 2
container_start_page e22636
container_title Curēus (Palo Alto, CA)
container_volume 14
creator Rivera, Ana P
Flores Monar, Gabriela Vanessa
Islam, Hamza
Puttagunta, Sri Madhurima
Islam, Rabia
Kundu, Sumana
Jha, Surajkumar B
Sange, Ibrahim
description Inflammatory bowel disease (IBD) is a chronic inflammatory gastrointestinal ailment that encompasses Crohn's disease (CD) and ulcerative colitis (UC). UC is an idiopathic, chronic inflammatory condition of the colonic mucosa that begins in the rectum and progresses proximally in a continuous way over a portion of the entire colon. Chronic inflammation is linked to cancer, and IBD-related chronic colonic inflammation raises the risk of colorectal cancer. Chronic inflammation has been linked to cancer, and chronic colonic inflammation caused by IBD increases the risk of colorectal cancer (CRC). When CRC arises in people with IBD, unlike sporadic CRC, the lesions are difficult to identify due to mucosal alterations produced by inflammation. The total prevalence of IBD-associated CRC is increasing due to the rapidly increasing frequency of IBD. Screening and surveillance colonoscopy in IBD patients is considered to allow for the early diagnosis of dysplasia and cancer, improving the prognosis of IBD-related CRC by giving patients proactive therapy. This article has reviewed literature pertaining to the mechanisms related to CRC development in UC and its clinical and therapeutic implications.
doi_str_mv 10.7759/cureus.22636
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8959421</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2657631485</sourcerecordid><originalsourceid>FETCH-LOGICAL-c342t-92e6377efb6b7ad692652bf74fc8e068d49a37ee07ba160bda79be58aa13ef723</originalsourceid><addsrcrecordid>eNpdkUtLxDAURoMoKjo711Jw48KOebR5uBCG-hoYcOOsQ5reaqSTaNIK_ns7joq6yg33cLgfH0JHBE-FKNW5HSIMaUopZ3wL7VPCZS6JLLZ_zXtoktIzxphgQbHAu2iPlUwQIeU-Wiw7C9H07g2yKnSudymf-2aw0Kz_IYLtTZdVJlrnw8pcZLPsCjroIbowpJHx1vTgR0Pwh2inNV2Cydd7gJY31w_VXb64v51Xs0VuWUH7XFHgTAhoa14L03BFeUnrVhStlYC5bAplmADAojaE47oxQtVQSmMIg1ZQdoAuN96XoV5BY8H30XT6JbqVie86GKf_brx70o_hTUtVqoKSUXD6JYjhdYDU65VLFrrOeBhTacoLrpiiao2e_EOfwxD9GG-kSsEZKWQ5UmcbysaQUoT25xiC9bopvWlKfzY14se_A_zA372wD81BkSU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2657631485</pqid></control><display><type>article</type><title>Ulcerative Colitis-Induced Colorectal Carcinoma: A Deleterious Concatenation</title><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Rivera, Ana P ; Flores Monar, Gabriela Vanessa ; Islam, Hamza ; Puttagunta, Sri Madhurima ; Islam, Rabia ; Kundu, Sumana ; Jha, Surajkumar B ; Sange, Ibrahim</creator><creatorcontrib>Rivera, Ana P ; Flores Monar, Gabriela Vanessa ; Islam, Hamza ; Puttagunta, Sri Madhurima ; Islam, Rabia ; Kundu, Sumana ; Jha, Surajkumar B ; Sange, Ibrahim</creatorcontrib><description>Inflammatory bowel disease (IBD) is a chronic inflammatory gastrointestinal ailment that encompasses Crohn's disease (CD) and ulcerative colitis (UC). UC is an idiopathic, chronic inflammatory condition of the colonic mucosa that begins in the rectum and progresses proximally in a continuous way over a portion of the entire colon. Chronic inflammation is linked to cancer, and IBD-related chronic colonic inflammation raises the risk of colorectal cancer. Chronic inflammation has been linked to cancer, and chronic colonic inflammation caused by IBD increases the risk of colorectal cancer (CRC). When CRC arises in people with IBD, unlike sporadic CRC, the lesions are difficult to identify due to mucosal alterations produced by inflammation. The total prevalence of IBD-associated CRC is increasing due to the rapidly increasing frequency of IBD. Screening and surveillance colonoscopy in IBD patients is considered to allow for the early diagnosis of dysplasia and cancer, improving the prognosis of IBD-related CRC by giving patients proactive therapy. This article has reviewed literature pertaining to the mechanisms related to CRC development in UC and its clinical and therapeutic implications.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.22636</identifier><identifier>PMID: 35371788</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Antibiotics ; Cancer ; Chronic illnesses ; Colon ; Colorectal cancer ; Crohn's disease ; Gastroenterology ; Inflammation ; Inflammatory bowel disease ; Inflammatory diseases ; Internal Medicine ; Large intestine ; Microbiota ; Oncology ; Pathogenesis ; Pathophysiology ; Patients ; Population ; Rectum ; Remission (Medicine) ; Steroids</subject><ispartof>Curēus (Palo Alto, CA), 2022-02, Vol.14 (2), p.e22636-e22636</ispartof><rights>Copyright © 2022, Rivera et al.</rights><rights>Copyright © 2022, Rivera et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2022, Rivera et al. 2022 Rivera et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c342t-92e6377efb6b7ad692652bf74fc8e068d49a37ee07ba160bda79be58aa13ef723</citedby><cites>FETCH-LOGICAL-c342t-92e6377efb6b7ad692652bf74fc8e068d49a37ee07ba160bda79be58aa13ef723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959421/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959421/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35371788$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rivera, Ana P</creatorcontrib><creatorcontrib>Flores Monar, Gabriela Vanessa</creatorcontrib><creatorcontrib>Islam, Hamza</creatorcontrib><creatorcontrib>Puttagunta, Sri Madhurima</creatorcontrib><creatorcontrib>Islam, Rabia</creatorcontrib><creatorcontrib>Kundu, Sumana</creatorcontrib><creatorcontrib>Jha, Surajkumar B</creatorcontrib><creatorcontrib>Sange, Ibrahim</creatorcontrib><title>Ulcerative Colitis-Induced Colorectal Carcinoma: A Deleterious Concatenation</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Inflammatory bowel disease (IBD) is a chronic inflammatory gastrointestinal ailment that encompasses Crohn's disease (CD) and ulcerative colitis (UC). UC is an idiopathic, chronic inflammatory condition of the colonic mucosa that begins in the rectum and progresses proximally in a continuous way over a portion of the entire colon. Chronic inflammation is linked to cancer, and IBD-related chronic colonic inflammation raises the risk of colorectal cancer. Chronic inflammation has been linked to cancer, and chronic colonic inflammation caused by IBD increases the risk of colorectal cancer (CRC). When CRC arises in people with IBD, unlike sporadic CRC, the lesions are difficult to identify due to mucosal alterations produced by inflammation. The total prevalence of IBD-associated CRC is increasing due to the rapidly increasing frequency of IBD. Screening and surveillance colonoscopy in IBD patients is considered to allow for the early diagnosis of dysplasia and cancer, improving the prognosis of IBD-related CRC by giving patients proactive therapy. This article has reviewed literature pertaining to the mechanisms related to CRC development in UC and its clinical and therapeutic implications.</description><subject>Antibiotics</subject><subject>Cancer</subject><subject>Chronic illnesses</subject><subject>Colon</subject><subject>Colorectal cancer</subject><subject>Crohn's disease</subject><subject>Gastroenterology</subject><subject>Inflammation</subject><subject>Inflammatory bowel disease</subject><subject>Inflammatory diseases</subject><subject>Internal Medicine</subject><subject>Large intestine</subject><subject>Microbiota</subject><subject>Oncology</subject><subject>Pathogenesis</subject><subject>Pathophysiology</subject><subject>Patients</subject><subject>Population</subject><subject>Rectum</subject><subject>Remission (Medicine)</subject><subject>Steroids</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkUtLxDAURoMoKjo711Jw48KOebR5uBCG-hoYcOOsQ5reaqSTaNIK_ns7joq6yg33cLgfH0JHBE-FKNW5HSIMaUopZ3wL7VPCZS6JLLZ_zXtoktIzxphgQbHAu2iPlUwQIeU-Wiw7C9H07g2yKnSudymf-2aw0Kz_IYLtTZdVJlrnw8pcZLPsCjroIbowpJHx1vTgR0Pwh2inNV2Cydd7gJY31w_VXb64v51Xs0VuWUH7XFHgTAhoa14L03BFeUnrVhStlYC5bAplmADAojaE47oxQtVQSmMIg1ZQdoAuN96XoV5BY8H30XT6JbqVie86GKf_brx70o_hTUtVqoKSUXD6JYjhdYDU65VLFrrOeBhTacoLrpiiao2e_EOfwxD9GG-kSsEZKWQ5UmcbysaQUoT25xiC9bopvWlKfzY14se_A_zA372wD81BkSU</recordid><startdate>20220226</startdate><enddate>20220226</enddate><creator>Rivera, Ana P</creator><creator>Flores Monar, Gabriela Vanessa</creator><creator>Islam, Hamza</creator><creator>Puttagunta, Sri Madhurima</creator><creator>Islam, Rabia</creator><creator>Kundu, Sumana</creator><creator>Jha, Surajkumar B</creator><creator>Sange, Ibrahim</creator><general>Cureus Inc</general><general>Cureus</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220226</creationdate><title>Ulcerative Colitis-Induced Colorectal Carcinoma: A Deleterious Concatenation</title><author>Rivera, Ana P ; Flores Monar, Gabriela Vanessa ; Islam, Hamza ; Puttagunta, Sri Madhurima ; Islam, Rabia ; Kundu, Sumana ; Jha, Surajkumar B ; Sange, Ibrahim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c342t-92e6377efb6b7ad692652bf74fc8e068d49a37ee07ba160bda79be58aa13ef723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibiotics</topic><topic>Cancer</topic><topic>Chronic illnesses</topic><topic>Colon</topic><topic>Colorectal cancer</topic><topic>Crohn's disease</topic><topic>Gastroenterology</topic><topic>Inflammation</topic><topic>Inflammatory bowel disease</topic><topic>Inflammatory diseases</topic><topic>Internal Medicine</topic><topic>Large intestine</topic><topic>Microbiota</topic><topic>Oncology</topic><topic>Pathogenesis</topic><topic>Pathophysiology</topic><topic>Patients</topic><topic>Population</topic><topic>Rectum</topic><topic>Remission (Medicine)</topic><topic>Steroids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rivera, Ana P</creatorcontrib><creatorcontrib>Flores Monar, Gabriela Vanessa</creatorcontrib><creatorcontrib>Islam, Hamza</creatorcontrib><creatorcontrib>Puttagunta, Sri Madhurima</creatorcontrib><creatorcontrib>Islam, Rabia</creatorcontrib><creatorcontrib>Kundu, Sumana</creatorcontrib><creatorcontrib>Jha, Surajkumar B</creatorcontrib><creatorcontrib>Sange, Ibrahim</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rivera, Ana P</au><au>Flores Monar, Gabriela Vanessa</au><au>Islam, Hamza</au><au>Puttagunta, Sri Madhurima</au><au>Islam, Rabia</au><au>Kundu, Sumana</au><au>Jha, Surajkumar B</au><au>Sange, Ibrahim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ulcerative Colitis-Induced Colorectal Carcinoma: A Deleterious Concatenation</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2022-02-26</date><risdate>2022</risdate><volume>14</volume><issue>2</issue><spage>e22636</spage><epage>e22636</epage><pages>e22636-e22636</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Inflammatory bowel disease (IBD) is a chronic inflammatory gastrointestinal ailment that encompasses Crohn's disease (CD) and ulcerative colitis (UC). UC is an idiopathic, chronic inflammatory condition of the colonic mucosa that begins in the rectum and progresses proximally in a continuous way over a portion of the entire colon. Chronic inflammation is linked to cancer, and IBD-related chronic colonic inflammation raises the risk of colorectal cancer. Chronic inflammation has been linked to cancer, and chronic colonic inflammation caused by IBD increases the risk of colorectal cancer (CRC). When CRC arises in people with IBD, unlike sporadic CRC, the lesions are difficult to identify due to mucosal alterations produced by inflammation. The total prevalence of IBD-associated CRC is increasing due to the rapidly increasing frequency of IBD. Screening and surveillance colonoscopy in IBD patients is considered to allow for the early diagnosis of dysplasia and cancer, improving the prognosis of IBD-related CRC by giving patients proactive therapy. This article has reviewed literature pertaining to the mechanisms related to CRC development in UC and its clinical and therapeutic implications.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>35371788</pmid><doi>10.7759/cureus.22636</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-8184
ispartof Curēus (Palo Alto, CA), 2022-02, Vol.14 (2), p.e22636-e22636
issn 2168-8184
2168-8184
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8959421
source PubMed Central; PubMed Central Open Access
subjects Antibiotics
Cancer
Chronic illnesses
Colon
Colorectal cancer
Crohn's disease
Gastroenterology
Inflammation
Inflammatory bowel disease
Inflammatory diseases
Internal Medicine
Large intestine
Microbiota
Oncology
Pathogenesis
Pathophysiology
Patients
Population
Rectum
Remission (Medicine)
Steroids
title Ulcerative Colitis-Induced Colorectal Carcinoma: A Deleterious Concatenation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T04%3A51%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ulcerative%20Colitis-Induced%20Colorectal%20Carcinoma:%20A%20Deleterious%20Concatenation&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Rivera,%20Ana%20P&rft.date=2022-02-26&rft.volume=14&rft.issue=2&rft.spage=e22636&rft.epage=e22636&rft.pages=e22636-e22636&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.22636&rft_dat=%3Cproquest_pubme%3E2657631485%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2657631485&rft_id=info:pmid/35371788&rfr_iscdi=true